ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Immuron Ltd

Immuron Ltd (IMRN)

2.64
-0.06
(-2.22%)
Closed July 20 4:00PM
2.64
0.00
(0.00%)
After Hours: 6:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
2.64
Bid
2.41
Ask
2.84
Volume
686
2.62 Day's Range 2.69
0.00 52 Week Range 0.00
Market Cap
Previous Close
2.70
Open
2.69
Last Trade
278
@
2.64
Last Trade Time
Financial Volume
$ 1,805
VWAP
2.6316
Average Volume (3m)
-
Shares Outstanding
5,694,959
Dividend Yield
-
PE Ratio
-0.15
Earnings Per Share (EPS)
-0.67
Revenue
4.4M
Net Profit
-3.79M

About Immuron Ltd

Immuron Limited is commercializing and developing a novel class of specifically targeted polyclonal antibodies which are delivered within the gastrointestinal tract and do not cross into the bloodstream. Products in clinical development have the potential to transform standard of care for moderate t... Immuron Limited is commercializing and developing a novel class of specifically targeted polyclonal antibodies which are delivered within the gastrointestinal tract and do not cross into the bloodstream. Products in clinical development have the potential to transform standard of care for moderate to severe Campylobacteriosis, Clostridioides difficile infections, Enterotoxigenic Escherichia coli (ETEC) infections and Traveler¿s Diarrhea. Immuron markets Travelan® in Australia, Canada and the U.S. In Australia, Travelan® is indicated to reduce the risk of travelers' diarrhea and to reduce the risk of minor gastro-intestinal disorders. In Canada, Travelan® is indicated to reduce the risk of travelers' diarrhea. In the U.S, Travelan® is a dietary supplement for digestive tract protection. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Melbourne, Victoria, Aus
Founded
1970
Immuron Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMRN. The last closing price for Immuron was $2.70. Over the last year, Immuron shares have traded in a share price range of $ 0.00 to $ 0.00.

Immuron currently has 5,694,959 shares outstanding. The market capitalization of Immuron is $15.38 million. Immuron has a price to earnings ratio (PE ratio) of -0.15.

IMRN Latest News

Immuron announces record Travelan® sales globally, Australia and USA

Sales Highlights: Global• FY 2024 AUD$4.9 million up 174% on prior comparative period (pcp)  • June 2024 Quarter AUD$1.3 million up 253% on pcp and 6% on prior quarter    Australia• FY 2024...

Immuron requests pre-IND meeting for IMM-529 with FDA filing

MELBOURNE, Australia, July 02, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce...

Immuron CEO Steven Lydeamore to present at Peak Sky High

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to advise our...

Immuron Board Changes

MELBOURNE, Australia, May 31, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Dr Roger...

Immuron Director Resignation

MELBOURNE, Australia, May 03, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, advises that Stephen...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SERVServe Robotics Inc
$ 7.51
(185.55%)
262.73M
AUGXAugmedix Inc
$ 2.27
(147.71%)
21.87M
XCURExicure Inc
$ 0.5351
(76.02%)
14.02M
PSNLPersonalis Inc
$ 3.83
(56.33%)
22.76M
MDBHMDB Capital Holdings LLC
$ 10.675
(37.21%)
126.13k
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
119.98M
HYZNHyzon Motors Inc
$ 0.149
(-47.54%)
23.37M
MEDSTRxADE Health Inc
$ 14.92
(-33.45%)
204.34k
SILOSilo Pharma Inc
$ 2.50
(-27.95%)
11.12M
KITTNauticus Robotics Inc
$ 0.0935
(-27.46%)
26.52M
SERVServe Robotics Inc
$ 7.51
(185.55%)
266.26M
SXTP60 Degrees Pharmaceuticals Inc
$ 0.2602
(5.77%)
226.82M
NVDANVIDIA Corporation
$ 117.93
(-2.61%)
217.11M
SQQQProShares UltraPro Short QQQ
$ 8.46
(2.79%)
188.2M
SPWRSunPower Corporation
$ 0.6735
(-55.40%)
124.61M

IMRN Discussion

View Posts
Monksdream Monksdream 2 weeks ago
IMRN under $2
👍️0
Pisd Pisd 2 weeks ago
..$2 left for dead..army contract/fda approval/etc..da-moon, loaded...
👍️0
Pisd Pisd 2 months ago
...reloading IMRN$$;;sleeper money maker for the patient imo, gl...
👍️0
Pisd Pisd 4 months ago
..will buy back little over $2 and lower, gl..
👍️0
Viewmont Viewmont 4 months ago
$IMRN Going up! News! March 07, 2024 (GLOBE NEWSWIRE)
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
Immuron proceeding to Phase 3 registration strategy with the FDA
Travelan® topline clinical trial results demonstrate protective efficacy with single daily dose
https://finance.yahoo.com/news/immuron-announces-positive-results-support-110000104.html

https://www.immuron.com.au/
👍️0
Viewmont Viewmont 4 months ago
$IMRN https://www.immuron.com.au/
👍️0
Viewmont Viewmont 4 months ago
Great news! Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
👍️0
Awl416 Awl416 4 months ago
Oops
👍️0
Jess070283 Jess070283 4 months ago
Yesssss!
👍️0
subslover subslover 4 months ago
52-week high has been SHATTERED!
👍️0
Jess070283 Jess070283 4 months ago
Watch thing rocket up out the gate IMO
👍️0
Monksdream Monksdream 4 months ago
Already read it earlier this am
👍️0
subslover subslover 4 months ago
LMFAO>
👍️0
tw0122 tw0122 4 months ago
It has the runs this morning
👍️0
subslover subslover 4 months ago
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US
https://www.otcmarkets.com/stock/IMRN/news/story?e&id=2788683
👍️0
Monksdream Monksdream 4 months ago
Moomoo wash trader this morning
👍️0
Monksdream Monksdream 5 months ago
IMRN 10Q 2/26
👍️0
Monksdream Monksdream 5 months ago
IMRN under $2
👍️0
Pisd Pisd 9 months ago
Immuron achieves record quarterly Travelan® sales

Highlights:

- Record quarterly Travelan® sales of $1,550,240
- Total sales of A$1,565,767 in Q1, FY24
- $1,508,933 increase on Q1, FY23 sales
- 130% higher than pre-pandemic period Q1, FY20 sales


Melbourne, Australia, October 11, 2023: Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce record quarterly sales (unaudited net sales) of its over-the-counter gastrointestinal and digestive health immune supplement Travelan®.


Australia

Immuron previously reported (August 9, 2023) that short term stock outages of Travelan® in some wholesalers and pharmacies in the June 2023 quarter was resolved following receipt of GMP Clearance from the Therapeutic Goods Administration (TGA). Immuron has since supplied product to wholesalers who in turn have supplied retail pharmacies.

Sales of Travelan® increased to AUD $1,339,160 in Q1, FY24, compared to AUD $25,565 in Q1, FY23. Sales increased by $940,991 (236%) on the pre-pandemic peak period (Q1, FY20).

This increase partially reflects 3 months (May, June, July) of backorders accrued while awaiting GMP Clearance from the TGA.

Immuron anticipates continued demand for replenishment of Travelan® as retail pharmacies sell to consumers. Australian Bureau of Statistics: short term resident returns in July 2023 were 48% higher than July 2022 and approaching pre-pandemic levels (89% of July 2019)1. Cumulative short term resident returns in the 12 months to July 2023 were 77% of those in the pre-pandemic period 12 months to July 2019. 1



USA

Sales of Travelan® increased to AUD $211,080 in Q1, FY24, compared to AUD $16,614 in Q1, FY23. Sales were lower by $20,499 (-9%) on the pre-pandemic peak period (Q1, FY20).

International Trade Administration Total U.S. citizen international visitor departures from the United States in June 2023 increased 20.2% compared to June 2022 and were 99.4% of total departures in June 2019. 2
👍️0
Pisd Pisd 9 months ago
..crazy lol .. IMRN$ ...
👍️0
Monksdream Monksdream 10 months ago
IMRN under $2
👍️0
Triple nickle Triple nickle 1 year ago
Here we gooooo
👍️0
Pisd Pisd 1 year ago
Gonna hold on here.. IMRN$...
👍️0
knrorrel knrorrel 1 year ago
IMRN good News Out running hard

imho





👍️0
Pisd Pisd 1 year ago
Finally something going up.. IMRN$...
👍️0
subslover subslover 1 year ago
That's great news! Thanks.
👍️0
tw0122 tw0122 1 year ago
Immuron Announces FDA Removed Clinical Hold on New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation

Source: GlobeNewswire Inc.

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to announce that the US Naval Medical Research Center (NMRC) has received approval from the US Food and Drug Administration (FDA) to proceed with the clinical evaluation of a new oral therapeutic targeting Campylobacter and Enterotoxigenic Escherichia coli (ETEC) developed in collaboration with Immuron. The FDA has removed a clinical hold on the Investigational New Drug (IND) application allowing the NMRC to proceed with its plans to evaluate the efficacy of the hyperimmune product to prevent infectious diarrhoea cause
👍️0
DK11 DK11 1 year ago
https://www.sec.gov/Archives/edgar/data/1660046/000121390023012017/ea173668ex99-1_immuron.htm
I guess for those who Travel a lot, some relief.
👍️0
THEMASTERS_SON THEMASTERS_SON 2 years ago
…skip
👍️0
THEMASTERS_SON THEMASTERS_SON 2 years ago
,,,,,,,We’ll break $3 shortly! FASHOO!!!
👍️0
THEMASTERS_SON THEMASTERS_SON 2 years ago
,,,,,,,COVER YOU MORONS WEEEEEE!
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=IMRN&p=d
👍️0
THEMASTERS_SON THEMASTERS_SON 2 years ago
,,,,,,,SUPER CHEAP
👍️0
TheFinalCD TheFinalCD 2 years ago
thanks for the heads up
👍️0
subslover subslover 2 years ago
Immuron Receives FDA Approval for Travelan IND Application
December 23 2022 - 06:00AM
GlobeNewswire Inc.
Alert
Print
Share On Facebook

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company that has developed two commercially available oral immunotherapeutic products for the treatment of gut mediated diseases, is pleased to announce that it has received approval from the US Food and Drug Administration to proceed with the clinical evaluation of Travelan. The Investigational New Drug (IND) application to evaluate the efficacy of a single dose of Travelan to prevent infectious diarrhea caused by ETEC is now active.
As a result of this approval the company will proceed with the planned clinical trial in the United States. The safety and protective efficacy of Travelan will be tested utilizing a controlled human infection-model clinical trial design.

Immuron is the sponsor of the IND, and the clinical study will be conducted by the Contract Research Organisation Pharmaron CPC, Inc (ASX announcement October 4, 2022) at its FDA inspected clinical research facility located in Baltimore, Maryland in the USA.

The Phase II clinical trial will evaluate the efficacy of a single dose regimen of Travelan® in a controlled human infection model (CHIM) using the enterotoxigenic Escherichia coli (ETEC) strain H10407. The clinical study aims to enrol up to 60 healthy adult subjects each will be randomly assigned to receive either a once-daily dose of 1200 mg of Travelan® (30 subjects) or placebo (30 subjects). Recruitment is planned to be initiated in 1H 2023 with headline results from the clinical trial expected to be reported by year end 2023.

Infectious diarrhea is the most common illness reported by travelers visiting developing countries and among US troops deployed overseas. The morbidity and associated discomfort stemming from diarrhea decreases daily performance, affects judgment, decreases morale and declines operational readiness. The first line of treatment for infectious diarrhea is the prescription of antibiotics. Unfortunately, in the last decade, several enteric pathogens have an increasing resistance to commonly prescribed antibiotics. In addition, travelers' diarrhea is now recognized by the medical community to result in post-infectious sequelae, including post-infectious Irritable Bowel Syndrome and several post-infectious autoimmune diseases. A preventative treatment that protects against enteric diseases, is a high priority objective for the US Military.

This release has been authorised by the directors of Immuron Limited.

COMPANY CONTACT:

Steven Lydeamore
Chief Executive Officer
Ph: +61 (0)3 9824 5254
info@immuron.com

For more information visit: http://www.immuron.com



Primary Logo

Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Immuron Charts. Immuron (NASDAQ:IMRN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Immuron Charts.
👍️0
Soulman856 Soulman856 2 years ago
Making a run here today
👍️0
Tim Tim 2 years ago
Nice:
Immuron Limited (the “Company”) published one announcement (the “Public Notices”) to the Australian Securities Exchange on April 27, 2022 titled:

- “Immuron Q3 Global Sales up 216% YoY”
👍️0
Man6677 Man6677 2 years ago
Thank you !
👍️0
Pisd Pisd 2 years ago
btw Immuron warrants expire May 12th ..$10 gl...




👍️0
Man6677 Man6677 2 years ago
I think IMRN is a good buy here .

GLTA !
👍️0
Pisd Pisd 3 years ago
Maybe they learned a lesson?..develop Covid pill lol IMRN$..




👍️0
Pisd Pisd 3 years ago
Sold when director left $4.70..buyer today $3.55 IMRN$...




👍️0
Pisd Pisd 3 years ago
Covid pill in development same as RVVTF$, gl...




👍️0
Pisd Pisd 3 years ago
Quiet here, good! ..waiting IMRN$...
👍️0
Pisd Pisd 3 years ago
Everybody asleep here..one day get woken up imo.. IMRN/W$...
👍️0
Pisd Pisd 3 years ago
A gift at $5.20 today.. total sleeper atm.. IMRN$...



👍️0
Pisd Pisd 3 years ago
https://www.wsj.com/articles/next-generation-of-covid-19-vaccines-could-be-pill-or-spray-11620034381?siteid=yhoof2&yptr=yahoo




👍️0
Pisd Pisd 3 years ago
Reiterate..holding IMRN$$..covid pill, travelers disease..etc might add $5ish, gl...


👍️0
Pisd Pisd 3 years ago
...please tell
👍️0
calculatedrisk calculatedrisk 3 years ago
JUST LOADED UP ON THIS ONE....NEWS IMMINENT....$18-$22 BY EOW
👍️0

Your Recent History

Delayed Upgrade Clock